scholarly journals P024: A retrospective chart review of the length of stay of patients presenting to the emergency department with a drug overdose

CJEM ◽  
2020 ◽  
Vol 22 (S1) ◽  
pp. S73-S73
Author(s):  
R. Soegtrop ◽  
K. Van Aarsen ◽  
M. Columbus ◽  
A. Dong

Introduction: Patients who present to the Emergency Department (ED) with a drug overdose often require long periods of monitoring. After their initial assessment and stabilization, they spend a significant amount of time in a high cost acute care bed in the ED for monitoring until they are medically cleared for psychiatric care or to be discharged. The shift length at this ED is a maximum of 8 hours; meaning any patients staying over 8 hours must be handed over between physicians, increasing the chance of medical errors. The objective of this study is to examine the total ED length of stay (LOS) of this patient group after physician initial assessment (PIA) to determine if there is there justification for the creation of a toxicology observation or short-stay unit for these patients. Methods: A single-centre, blinded retrospective chart review was conducted examining all adult patients presenting to the ED at an urban academic tertiary care centre with a drug overdose in 2018. Variables examined include: Disposition (home, admitted to acute care setting, admitted to non-acute care setting), time from PIA to disposition and total length of stay from PIA to discharge home or admission to hospital. The primary outcome is total length of stay in the ED after PIA.M Results: A total of 1006 patients presenting with an overdose were included. A total of 388 patients were admitted with 44% (172) having an ED LOS greater than 8 hours and 36% (138) staying 8 hours after PIA. The median [IQR] LOS in the ED for all patients was 343 minutes [191-565] while the median [IQR] time to PIA was 37 minutes [15-97]. The majority of these patients (54%) were discharged with no consulting services involved, 23% received a consult to psychiatry, 22% were consulted to internal medicine and 5% of patients were consulted to Critical Care Medicine. Conclusion: This demonstrates patients presenting to the ED with an overdose are seen in the ED by a physician quickly, however many stay in the department over 5 hours from their initial assessment in a monitored setting. While a majority of these patients are able to go home, 44% of admitted patients wait greater than 8 hours in the ED on monitors. The creation of a toxicology observation unit would be helpful for this population to increase patient safety and ease ED bed congestion.

2018 ◽  
Vol 27 (7-8) ◽  
pp. e1429-e1441 ◽  
Author(s):  
Rhonda L Babine ◽  
Kristiina E Hyrkäs ◽  
Sarah Hallen ◽  
Heidi R Wierman ◽  
Deborah A Bachand ◽  
...  

2018 ◽  
Author(s):  
Jason J Lewis ◽  
Richard E Wolfe

Nondiabetic endocrine emergencies are less frequent but equally concerning as diabetic emergencies. The diagnosis of adrenal crises, pheochromocytoma, or pituitary deficiencies can be difficult in the emergent setting given the nonspecific findings frequently confused with other presenting illnesses. Although the differential is broad for patients presenting with shock and hypotension, as seen in adrenal crises, hypertensive emergencies in pheochromocytoma, or a litany of potential symptoms in pituitary abnormalities, the diagnosis should be considered in a patient presenting to the emergency department with severe metabolic abnormalities, undifferentiated shock, or cardiovascular lability. This review demonstrates how to recognize and manage acute adrenal crisis, pheochromocytoma, and pituitary deficiencies in the acute care setting. Patients with nondiabetic endocrine emergencies may present in extremis, and immediate stabilization, typically without confirmatory testing, is necessary. Early intervention is key in treating such presentations. This review contains 1 figure, 2 tables and 21 references Key words: adrenal crisis, adrenal insufficiency, catecholamine surge, pheochromocytoma, pituitary deficiency


2011 ◽  
Vol 6 (1) ◽  
pp. 85-86
Author(s):  
J. Bauer ◽  
K. Hiscocks ◽  
R. Fichera ◽  
P. Horsley ◽  
J. Martineau ◽  
...  

2020 ◽  
Vol 120 (12) ◽  
pp. 1654-1667
Author(s):  
Alicia A. C. Waite ◽  
David O. Hamilton ◽  
Roberto Pizzi ◽  
Walter Ageno ◽  
Ingeborg D. Welters

AbstractCOVID-19 was first described in late 2019 and has since developed into a pandemic affecting more than 21 million people worldwide. Of particular relevance for acute care is the occurrence of COVID-19-associated coagulopathy (CAC), which is characterised by hypercoagulability, immunothrombosis and venous thromboembolism, and contributes to hypoxia in a significant proportion of patients. This review describes diagnosis and treatment of CAC in the emergency department and in intensive care. We summarise the pathological mechanisms and common complications of CAC such as pulmonary thrombosis and venous thromboembolic events and discuss current strategies for thromboprophylaxis and therapeutic anti-coagulation in the acute care setting.


2014 ◽  
Vol 1 (suppl_1) ◽  
pp. S435-S435
Author(s):  
Vanessa Stevens ◽  
Karim Khader ◽  
Richard E. Nelson ◽  
Makoto Jones ◽  
Michael Rubin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document